Arcutis Biotherapeutics, Inc.
ARQT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001787306
In the last 90 days, Arcutis Biotherapeutics, Inc. insiders filed 0 open-market purchases and 12 sales; 272 institutions reported holding it in 13F filings for Q2 2026, worth $3.45B in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Arcutis Biotherapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 136
- −8 vs. Q1 2023
- Shares held
- 71.8M
- +192.6K (+0.3%) vs. Q1 2023
- Total value
- $684.0M
- −$103.6M (−13.2%) vs. Q1 2023
- New holders
- 21
- 68 more added
- Sold out
- 29
- 28 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARQT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 272 | $3.45B |
| Q1 2026 | 270 | $3.12B |
| Q4 2025 | 283 | $3.75B |
| Q3 2025 | 239 | $2.37B |
| Q2 2025 | 230 | $1.78B |
| Q1 2025 | 241 | $1.97B |
| Q4 2024 | 208 | $1.79B |
| Q3 2024 | 188 | $1.20B |
| Q2 2024 | 186 | $1.18B |
| Q1 2024 | 168 | $1.24B |
| Q4 2023 | 133 | $327.1M |
| Q3 2023 | 134 | $356.7M |
| Q2 2023 | 136 | $684.0M |
| Q1 2023 | 144 | $787.6M |
| Q4 2022 | 141 | $979.6M |
| Q3 2022 | 139 | $1.13B |
| Q2 2022 | 115 | $1.05B |
| Q1 2022 | 106 | $929.8M |
| Q4 2021 | 93 | $961.8M |
| Q3 2021 | 103 | $1.09B |
| Q2 2021 | 102 | $1.24B |
| Q1 2021 | 94 | $1.35B |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Arcutis Biotherapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Neuberger Berman Group LLC | 241,846 | $2.30M | 0.00% | +58,831+32.1% | Added |
| Parallax Volatility Advisers, L.P. | 259,856 | $2.48M | 0.09% | +33,543+14.8% | Added |
| Weiss Multi-Strategy Advisers LLC | 268,947 | $2.56M | 0.06% | +141,011+110.2% | Added |
| AlphaCentric Advisors LLC | 292,500 | $2.79M | 1.55% | +102,500+53.9% | Added |
| Sio Capital Management, LLC | 293,047 | $2.79M | 0.99% | +293,047 | New |
| Charles Schwab Investment Management Inc | 329,942 | $3.14M | 0.00% | +27,440+9.1% | Added |
| Ameriprise Financial Inc | 337,052 | $3.21M | 0.00% | −517,682−60.6% | Reduced |
| Prudential Financial Inc | 363,415 | $3.46M | 0.01% | +200,585+123.2% | Added |
| Bank of America Corp | 406,555 | $3.87M | 0.00% | −1,215,219−74.9% | Reduced |
| AXA S.A. | 448,642 | $4.28M | 0.01% | +6,163+1.4% | Added |
| Northern Trust Corp | 465,653 | $4.44M | 0.00% | +78,792+20.4% | Added |
| Morgan Stanley | 485,978 | $4.63M | 0.00% | +148,324+43.9% | Added |
| Rafferty Asset Management, LLC | 499,922 | $4.76M | 0.03% | +195,216+64.1% | Added |
| American Century Companies Inc | 509,879 | $4.86M | 0.00% | +1,860+0.4% | Added |
| Goldman Sachs Group Inc | 694,321 | $6.62M | 0.00% | +447,345+181.1% | Added |
| Cormorant Asset Management, LP | 800,000 | $7.62M | 0.43% | +800,000 | New |
| Woodline Partners LP | 807,750 | $7.70M | 0.09% | +112,075+16.1% | Added |
| Ensign Peak Advisors, Inc | 832,540 | $7.93M | 0.02% | +346,300+71.2% | Added |
| Suvretta Capital Management, LLC | 872,427 | $8.31M | 0.45% | +193,036+28.4% | Added |
| Geode Capital Management, LLC | 937,447 | $8.93M | 0.00% | +129,080+16.0% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,105,309 | $10.5M | 3.47% | +536,268+94.2% | Added |
| Pictet Asset Management SA | 1,327,029 | $12.6M | 0.01% | −329,036−19.9% | Reduced |
| Holocene Advisors, LP | 1,440,036 | $13.7M | 0.06% | −629,141−30.4% | Reduced |
| Franklin Resources Inc | 1,652,536 | $15.7M | 0.01% | +59,166+3.7% | Added |
| OrbiMed Advisors LLC | 1,914,479 | $18.2M | 0.36% | 00.0% | Unchanged |
| GW&K Investment Management, LLC | 2,062,683 | $19.7M | 0.19% | +157,961+8.3% | Added |
| Marshall Wace, LLP | 2,317,541 | $22.1M | 0.05% | +12,205+0.5% | Added |
| Vanguard Group Inc | 2,650,388 | $25.3M | 0.00% | +68,257+2.6% | Added |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $28.6M | 2.94% | 00.0% | Unchanged |
| Polar Capital Holdings Plc | 3,127,777 | $29.8M | 0.20% | −7,736−0.2% | Reduced |
| BlackRock Inc. | 4,231,374 | $40.3M | 0.00% | −366,898−8.0% | Reduced |
| Jennison Associates LLC | 4,293,966 | $40.9M | 0.03% | +2,079,476+93.9% | Added |
| Rubric Capital Management LP | 4,884,530 | $46.5M | 1.99% | +1,384,530+39.6% | Added |
| State Street Corp | 5,226,009 | $49.8M | 0.00% | +1,611,228+44.6% | Added |
| Frazier Life Sciences Management, L.P. | 8,684,232 | $82.8M | 4.94% | 00.0% | Unchanged |
| FMR LLC | 9,212,786 | $87.8M | 0.01% | +50,356+0.5% | Added |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −1,628,500−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −1,114,111−100.0% | Sold out |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −502,000−100.0% | Sold out |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −415,322−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −273,599−100.0% | Sold out |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −254,137−100.0% | Sold out |
| Saturn V Capital Management LLC | 0 | $0 | 0.00% | −178,217−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −119,029−100.0% | Sold out |
| Martingale Asset Management L P | 0 | $0 | 0.00% | −46,904−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −44,288−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −42,914−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −40,244−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −33,914−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −30,296−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −30,306−100.0% | Sold out |
| Symmetry Investments LP | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Nebula Research & Development LLC | 0 | $0 | 0.00% | −25,976−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −16,000−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −14,648−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −14,644−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −10,629−100.0% | Sold out |
| Guggenheim Capital LLC | 0 | $0 | 0.00% | −10,531−100.0% | Sold out |
| First Republic Investment Management, Inc. | 0 | $0 | 0.00% | −10,058−100.0% | Sold out |
| WealthPLAN Partners, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −435−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −370−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −45,299−100.0% | Sold out |